Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
CNS Drugs|November 18, 2021
Molecular Mechanisms of Psilocybin and Implications for the Treatment of DepressionSusan Ling, Felicia Ceban, Leanna M W Lui, et al.
CNS Spectrums|December 10, 2020
Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulationNelson B Rodrigues, Ashley Siegel, Orly Lipsitz, et al.
Journal of Affective Disorders|June 23, 2021
Does pre-treatment functioning influence response to intravenous ketamine in adults with treatment-resistant depression?Roger S McIntyre, Orly Lipsitz, Leanna M W Lui, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|January 22, 2021
Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case SeriesOrly Lipsitz, Joshua D Di Vincenzo, Nelson B Rodrigues, et al.
CNS Drugs|September 13, 2022
A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic ReviewNiloufar Pouyan, Zahra Halvaei Khankahdani, Farnaz Younesi Sisi, et al.
CNS Spectrums|November 25, 2024
A systematic review on the efficacy of GLP-1 receptor agonists in mitigating psychotropic drug-related weight gainTrisha Menon, Serene Lee, Xuan Yi Gong, et al.
Molecular Psychiatry|May 14, 2026
How muscle talks to brain: apelin protein mediates exercise-induced antidepressant effectsJiasui Yu, Tong Cheng, Huihui Guo, et al.
Pageof 11